Fundz

Mbx Biosciences, Inc. reported raising $25.8 Million in an initial SEC Form D filing, from an offering of $35.8 Million

PUBLIC · MBXJul 27, 2020$25.8M of $35.8M raised

Amount Raised

$25.8 Million

$25.8 Million sold, per SEC Form D (first sale Jul 27, 2020)

Round Type

Venture

CarmelBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Quick answer

MBX Biosciences, Inc. raised $25.8 Million in a funding round, dated July 27, 2020. MBX Biosciences, Inc. is based in Carmel, Indiana, United States.

How much did MBX Biosciences, Inc. raise?
MBX Biosciences, Inc. raised $25.8 Million in a funding round on July 27, 2020.
What does MBX Biosciences, Inc. do?
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives.
Where is MBX Biosciences, Inc. based and how big is it?
MBX Biosciences, Inc. is based in Carmel, Indiana, United States.
Who are the decision-makers at MBX Biosciences, Inc?
Fundz holds 1 contact at MBX Biosciences, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as MBX Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at MBX Biosciences, Inc., and when

A new round usually means MBX Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MBX Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MBX Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MBX Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MBX Biosciences, Inc.

Location

11711 N. Meridian Street, Suite 300

Carmel, Indiana, United States

About

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives. The company is advancing a pipeline of PEPs for clinically validated targets designed to deliver superior pharmaceutical properties and overcome key limitations of native peptide therapeutics. MBX’s pipeline includes its lead product candidate MBX 2109, in Phase 2 development for the treatment of hypoparathyroidism (HP), MBX 1416, in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH) and multiple discovery and pre-clinical candidates in development for the treatment of obesity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MBX Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at MBX Biosciences, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MBX Biosciences, Inc.'s next move

See what Strategic adds

MBX Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.